A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy
Details
Age
Adult
Type of Study
Treatment
Locations
Childrens Hospital Colorado
University of Colorado Hospital
Principal Investigator
Bradley Dixon, MD
Study ID
Protocol Number: 21-4569
More information available at ClinicalTrials.gov: NCT04817618
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers